PFA
MURA

Pathway Financial Advisers’s Mural Oncology MURA Stock Holding History

Pathway Financial Advisers’s Portfolio MURA Stock Details MURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-532
Closed -$1.71K – 322
2024
Q4 		$1.71K Hold
532
– – ﹤0.01% 424
2024
Q3 		$1.66K Hold
532
– – ﹤0.01% 359
2024
Q2 		$1.67K Buy
532
+1
+0.2% +$4 ﹤0.01% 423
2024
Q1 		$2.6K Sell
531
-1
-0.2% -$5 ﹤0.01% 426
2023
Q4 		$3.15K Buy
+532
New +$2.14K ﹤0.01% 436

Other funds holding MURA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pathway Financial Advisers's MURA Position: Q1 2025 in Review

Pathway Financial Advisers sold out of Mural Oncology (MURA) in Q1 2025, closing a stake of 532 shares — an estimated $1.71K sold.

Pathway Financial Advisers first reported a position in MURA in Q4 2023 and held it in 5 quarters. The position peaked at $3.15K in Q4 2023. 68 funds tracked by Wall St. Rank hold MURA as of Q1 2025.

  • Pathway Financial Advisers reported no remaining Mural Oncology position as of Q1 2025 after selling out during the quarter.
  • Pathway Financial Advisers sold 532 Mural Oncology shares in Q1 2025, an estimated $1.71K.
  • Pathway Financial Advisers first reported a position in Mural Oncology in Q4 2023 and held it in 5 quarters.
  • Pathway Financial Advisers's Mural Oncology position peaked at $3.15K in Q4 2023.
  • 68 funds tracked by Wall St. Rank held Mural Oncology as of Q1 2025.

Based on Pathway Financial Advisers's 13F filing for Q1 2025, filed 9 May 2025.